Real-Time European Filings API. Request Access
BIOMARIN PHARMACEUTICAL INC Logo

BIOMARIN PHARMACEUTICAL INC

Develops and commercializes therapies for rare, life-threatening genetic diseases.

BMRN | US

Overview

Corporate Details

ISIN(s):
US09061G1013
LEI:
Country:
United States of America
Address:
105 DIGITAL DRIVE, 94949 NOVATO
Website:
https://www.biomarin.com/
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioMarin Pharmaceutical Inc. is a global biotechnology company dedicated to developing and commercializing transformative therapies for rare and life-threatening genetic diseases. Founded in 1997, the company leverages its scientific expertise in the underlying causes of genetic conditions to create first-in-class and best-in-class treatments. Its portfolio of marketed products addresses disorders such as achondroplasia, severe hemophilia A, and various lysosomal storage diseases, often utilizing enzyme replacement therapies (ERTs) and other advanced modalities. BioMarin also maintains an active pipeline of investigational medicines in various stages of clinical and preclinical development to address unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOMARIN PHARMACEUTICAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOMARIN PHARMACEUTICAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BIOMARIN PHARMACEUTICAL INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

scPharmaceuticals Inc. Logo
scPharmaceuticals Inc.
Commercializes subcutaneous drug-device therapies for at-home cardiorenal care.
United States of America
SCPH
SCYNEXIS INC Logo
SCYNEXIS INC
Developing novel anti-fungal therapies for difficult-to-treat, drug-resistant infections.
United States of America
SCYX
Seach Medical Group Ltd. Logo
Seach Medical Group Ltd.
Researches, cultivates, and produces certified medical cannabis oils and flowers for global markets.
Israel
SEMG
SEEGENE, INC. Logo
SEEGENE, INC.
Develops multiplex qPCR diagnostic assays and automated systems for labs and healthcare worldwide.
South Korea
096530
SEIKAGAKU CORPORATION Logo
SEIKAGAKU CORPORATION
A research pharma company using glycoscience to develop drugs for orthopedic & ophthalmic diseases.
Japan
4548
SELLAS Life Sciences Group, Inc. Logo
SELLAS Life Sciences Group, Inc.
Late-stage biopharma developing novel immunotherapies for a broad range of cancers.
United States of America
SLS
Sensei Biotherapeutics, Inc. Logo
Sensei Biotherapeutics, Inc.
Developing tumor-activated biologics to stimulate a targeted immune response against cancer.
United States of America
SNSE
Senti Biosciences, Inc. Logo
Senti Biosciences, Inc.
Developing smart cell and gene therapies with Gene Circuits to precisely target cancer.
United States of America
SNTI
SEOUL PHARMA CO.,LTD Logo
SEOUL PHARMA CO.,LTD
Develops pharmaceuticals with innovative Orally Disintegrating Film (ODF) tech for global markets.
South Korea
018680
Septerna, Inc. Logo
Septerna, Inc.
Advancing novel small molecule GPCR medicines for endocrine, immune, and metabolic diseases.
United States of America
SEPN

Talk to a Data Expert

Have a question? We'll get back to you promptly.